Skip to main content
Fig. 2 | Journal of Nanobiotechnology

Fig. 2

From: Theranostic nanoplatform to target macrophages enables the inhibition of atherosclerosis progression and fluorescence imaging of plaque in ApoE(−/−) mice

Fig. 2

Structure and characteristics of NMs. a-c FT-IR, UV–vis and zeta potential characterization to show the formation of CMSN@Anti. d-f The fluorescence stability of CMSN under 365 nm UV exposure, natural light and different pH buffers. g The fluorescence excitation and emission spectra of CMSN. h The UV–vis absorption spectra of CMSN and Rhodamine 6G. i The drug release curve of CMSN@SRT@Anti in PBS buffers with different pH values

Back to article page